Sequent Scientific Share Price
CMP as on 20-Jan-21 15:30
₹ 218.70Open
₹ 215.80Turnover (lac)
₹ 3,285Prev. Close
₹ 214.50Day's Vol (shares)
₹ 15,02,037CMP as on20-Jan-21 15:05
₹ 221.50Open
₹ 218.00Turnover (lac)
₹ 3Prev. Close
₹ 214.00Day's Vol (shares)
₹ 89,738News
-
SeQuent Scientific board nods Employee Stock Option Plan 2020; stock ends 2% hig
16:46 IST, Dec 15These stock options are each convertible into one (1) equity share of the Company having face value of Rs2 per equity share.
-
Board of Sequent Scientific appoints director
10:33 IST, Dec 15At meeting held on 14 December 2020
-
SeQuent announces launch of Citramox LA in EU
16:56 IST, Dec 10This new approval for SeQuent builds on the recent approvals of Tulazzin (Tulathromycin) and Halofusol (Halofuginone) in Europe.
-
Sequent Scientific launches Citramox? LA in Europe
14:34 IST, Dec 10Sequent Scientific launches Citramox? LA in Europe
-
SeQuent launches inhouse developed Halofusol in EU
16:26 IST, Dec 01The product had recently received approval from the European Medicines Agency (EMA) through its Spanish subsidiary Laboratorios Karizoo
-
SeQuent launches Halofusol oral solution for calves in EU
11:35 IST, Dec 01SeQuent launches Halofusol oral solution for calves in EU
-
Board of Sequent Scientific appoints director
20:12 IST, Nov 06At meeting held on 06 November 2020
-
Sequent Scientific consolidated net profit declines 0.14% in the September 2020
16:19 IST, Nov 06Sales rise 21.83% to Rs 346.27 crore
-
Sequent Scientific standalone net profit declines 9.53% in the September 2020 qu
15:26 IST, Nov 06Sales rise 35.17% to Rs 69.64 crore
-
Sequent Scientific spurts 5% on completing acquisition of Provet
14:47 IST, Nov 03The company completed the transaction on proposed acquisition of 40% stake from Huseyin Aydin in Provet through subsidiary Alivira Anim
